{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:07:55Z","timestamp":1761584875809,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015699","name":"Fresenius Medical Care North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.atherosclerosissup.2019.08.024","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T11:12:50Z","timestamp":1566040370000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipoprotein apheresis \u2013 Shortening of treatment intervals reduces cardiovascular events: Case reports"],"prefix":"10.1016","volume":"40","author":[{"given":"Theresa","family":"Berent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Berent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Sinzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib1","first-page":"229","article-title":"Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events","volume":"6","author":"Jaeger","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/eurheartj\/ehx178","article-title":"Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial","volume":"38","author":"Khan","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosissup.2012.10.015","article-title":"Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography","volume":"14","author":"Safarova","year":"2013","journal-title":"Atherosclerosis Suppl"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1744-9987.1998.tb00075.x","article-title":"Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?","volume":"2","author":"Kanemitsu","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.atherosclerosissup.2019.08.024_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0009-3084(94)90162-7","article-title":"Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART)","volume":"67\u201368","author":"Yamaguchi","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"9","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib6","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/ndt\/gfn127","article-title":"Protein adsorption during LDL-apheresis: proteomic analysis","volume":"23","author":"Dihazi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cyto.2011.04.003","article-title":"Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis","volume":"55","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosissup.2019.08.024_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosissup.2015.02.018","article-title":"Effects of different lipoprotein apheresis methods on serum protein levels","volume":"18","author":"Julius","year":"2015","journal-title":"Atherosclerosis Suppl"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2019.08.024_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(99)00177-X","article-title":"The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability","volume":"147","author":"Kroon","year":"1999","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568819300479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568819300479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:02:44Z","timestamp":1761584564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568819300479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":9,"alternative-id":["S1567568819300479"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2019.08.024","relation":{},"ISSN":["1567-5688"],"issn-type":[{"type":"print","value":"1567-5688"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein apheresis \u2013 Shortening of treatment intervals reduces cardiovascular events: Case reports","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Supplements","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2019.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}